SlideShare una empresa de Scribd logo
1 de 40
Chronic Fatigue Syndrome-
Current status
Presenter – Praveen Das
Chairperson – Aditya Hegde
Outline
• Introduction and evolution of the concept
• Definition
• Status in ICD
• Epidemiology
• Etiology
• Comorbidity and differential diagnosis
• Treatment
• Conclusions
Introduction
• Fatigue- a feeling of weariness, sleepiness or
irritability after a period of mental or bodily activity
(Comprehensive Text book of Psychiatry, 9th Edition)
• Tiredness- A feeling of a lessened capacity for work
and reduced efficiency of accomplishment, usually
accompanied by a sense of weariness and fatigue
(Medicinenet.com)
• Weakness-
a weak bodily state as expressed by reluctance to an
d difficulty in rising, a shuffling, disinclination to mov
e, eating slowly and a drooping posture
(The free dictionary.com)
Evolution of the concept
• 19th century - George Miller Beard -
“Neurasthenia”  syndrome of fatigue, anxiety,
headache, impotence, neuralgia and depression
• 1934 - outbreak of fatigue affecting large numbers of
doctors and nurses of Los Angeles County Hospital -
“Atypical poliomyelitis”
• 1955 - similar outbreak in Royal Free Hospital, United
Kingdom – “Royal Free disease” or “benign myalgic
encephalomyelitis”
Evolution of the concept
• In 1987 Chronic fatigue syndrome (CFS) first used to
describe condition resembling "chronic active
Epstein-Barr virus (EBV) infection" but with no
evidence of EBV as its cause
• In 1988, "Chronic fatigue syndrome: a working case
definition", the Holmes definition
• In 1994, CDC (Centers for disease control and
prevention) gave its case definition
CDC Guidelines
MAJOR CRITERION
Severe chronic fatigue for ≥ 6 months
• Not due to ongoing exertion or other medical
conditions
• Not substantially relieved by rest
• Significant interference with daily activities
(Fukuda et al, 1994)
CDC Guidelines
MINOR CRITERION
• Concurrent presence of 4 or more of 8 symptoms:
• Post-exertion malaise lasting > 24 hours
• Unrefreshing sleep
• Impairment of memory or concentration
• Muscle pain
• Pain in multiple joints without swelling or redness
• Headaches of a new type, pattern, or severity
• Tender lymph nodes in the neck or armpit
• Frequent or recurring sore throat that
(Fukuda et al, 1994)
ICD 10 CM (clinical modification)
Chronic Fatigue Unspecified - R53.82
• For ≥ 6 months  tired most of the time, trouble
concentrating and carrying out daily activities
• Other symptoms include
– mild fever
– lymphadenopathy
– headache
– myalgia
– arthralgia
– depression, and memory loss
• Not caused by ongoing exertion, not relieved by rest
Epidemiology
• Prevalence
– 0.4% -2.5% (UK general population)
(Jason LA et al 1999)
– 0.2-0.4% (USA general population)
• Annual direct medical costs - $7 billion in USA
• Mean age of onset 29-35 yrs
• 75% of affected patients are women
(Reyes M et al 2003,, Prins et al 2006)
Etiology- Biological
1. Viral infection
– Ebstein-Barr virus initially proposed
(James F Jones et al 1985)
– Later found to be not conclusive
– No clear causal relationship between infections and CFS
(Timothy Craig, 2003, Buschwald et al 1987)
2. Hypothalamic pituitary adrenal Axis dysfunction
– Mild hypocortisolism observed in cases of CFS
– HPA axis dysfunction not specific to CFS, symptoms like
inactivty in CFS can decrease Cortisol levels
(Van Den ede et al.,2007)
– Hypocortisolemia may predict a poorer response to CBT
(Harrison’s principles of internal medicine, 18th ed)
Etiology- Biological
3. Immunologic basis
– High pro inflammatory cytokines, high IL-1 levels in
CFS
(Maes M.,2012)
– NK cell dysfunction- either decrease in number or
impaired function
– increased levels of T regulatory cells (CD25+/FOXP3+)
CD4 T cells
– Lower activation of CD8 T cells
(Currio M., 2013)
– Allergies (atopy) and CFS
(Y’bars et al 2005)
Etiology- Biological
3. Immunological basis (contd)
– Serotonin and CFS – anti 5-HT autoimmune
activity could play a role in the pathophysiology of
CFS and the onset of physio-somatic symptoms
(Maes et al 2013)
Etiology- Biological
4. Genetics
– Concordance 55% in monozygotic and 20% in dizygotic
twins
(Buchwald et al, 2001)
– Sequence variation in genes coding for HTR2A serotonergic
receptor potentially enhancing its activity may be involved
in pathophysiology of CFS
(Smith et al.,2008)
– Differences observed in gene expression in exercise
responsive genes in terms of gene ontology in attempt to
explain fatigue which worsens post exercise in CFS
(Whistler et al.,2005)
Etiology- Biological
5. Neuroimaging
• Functional
– Reduced basal ganglia function in terms of decreased
activity of right caudate and right globus pallidus on fMRI
(Miller et al, 2014)
• Structural
– Reduced grey and white matter volume in the occipital
lobe and reduced grey matter in the right angular gyrus
and right parahippocampal gyrus on VBM in CFS patients
(Puri et al, 2012)
Etiology - Psychological
• Increased prevalence of maladaptive personality
features and personality disorders
• Prevalence of paranoid, schizoid, avoidant, obsessive-
compulsive and depressive personality disorders
significantly higher in CFS compared to normals
• Neuroticism frequently associated with CFS; patients
with CFS were found to be less extraverted
(Nater et al, 2010)
Cognitive deficits in CFS
• Impaired information processing speed (reaction
time)
(Cockshell et al, 2013)
• Impaired working memory and poor learning of
information
(Mitchiels 2001)
• Impaired working memory and alterations in motor
speed
(Majer et al.,`2008)
Differential Diagnoses - Medical
VERY COMMON (~1 PER 100)
Anemia
Thyroid disorders
Medications (statins)
Sleep apnea
COMMON (~1 PER 1,000)
Chronic infection: HIV, Hepatitis C
endocarditis, osteomyelitis, Lyme
disease, occult abscess
Cancer
Pulmonary conditions: asthma,
obstructive lung disease, interstitial lung
disease
Symptomatic hyperparathyroidism
UNCOMMON (~1 PER 10,000)
Polymyositis,
Dermatomyositis,
Myopathy
Myasthenia gravis,
Multiple sclerosis
Narcolepsy
Inflammatory bowel diseases
Overlapping “Functional Syndromes”
Functional Somatic Syndromes by Speciality
Gastroenterology Irritable Bowel Syndrome,
Non-Ulcer Dyspepsia
Gynaecology Chronic Pelvic Pain
Pre-menstrual syndrome
Rheumatology Fibromyalgia
Cardiology Atypical/Non-cardiac chest pain
DaCosta’s Syndrome
Respiratory Medicine Hyperventilation Syndrome
Dentistry Temporomandibular Joint Dysfunction/Atypical facial
pain
ENT Globus Hystericus
Allergy Multiple Chemical Sensitivity
Fibromyalgia
American College of Rheumatology (ACOR) Criteria for Fibromyalgia; Adapted
from Wolfe et al, 1990
Fibromyalgia vs CFS
• Most patients who have received the diagnosis of
one are also likely to meet the diagnostic criteria for
the other
• Simply put,
– CFS is fatigue with pain
– Fibromyalgia is pain with fatigue
(Sullivan et al, 2002)
D/D vs Comorbidity - Psychiatric
• Major Depression
• Anxiety disorders
• Somatoform disorder
• Hypochondriasis
• Neurasthenia
• Debated - whether psychiatric conditions are
Consequence / Cause / Co-incidental overlap of
symptoms
• Main overlapping symptoms - fatigue, sleep
disturbance, and poor concentration
CFS vs
Mood & Anxiety disorders
• A psychiatric disorder (in patients with an existing
diagnosis of CFS) was diagnosed in 45.2%; mostly
mood and anxiety disorder.
(Mariman et al.,2013)
• Studies of clinic attenders with CFS reported that
more than 25% have a current DSM major
depression diagnosis, and 50%–75% have a lifetime
diagnosis
(Skapinakis et al, 2000)
General
Population
CFS Patients
GAD 3.5% 30%
Panic Disorder 5.1% 25%
Barriers to making diagnosis
• Illness model- a biomedical approach by both
doctors (GP) and patients
• Poor communication between the patient and
the health professional
• Knowledge and attitudes- limited
understanding, limited training
• Low priority in the health care setup
(Kerin Bayliss et al, 2014)
Indian study
• Population survey- Goa
• 3000 women- between 18 and 50 yrs
• ‘Chronic fatigue’- reported by 12.1%
• Factors indicating gender disadvantage (notably
sexual violence by the husband and poor mental
health were strongly associated with chronic fatigue
(Vikram Patel et al, 2005)
Treatment - Principles
• Engagement: Building rapport, empathic
understanding of distress
• Developing a therapeutic rationale - individualize
• Evolution of a treatment plan: defined by
objective performance targets and time frames.
• Use psychopharmacology sparingly: Only when a
demonstrable symptom target can be seen
• Avoid invasive and/or expensive medical testing.
• Seek opportunities to clarify importance of
psychological factors as the therapy proceeds
(Comprehensive Textbook of Psychiatry 9th ed)
Treatment - Guidelines
NICE Guidelines (2007)
• General strategies
– Symptom management
– Function and quality of life management (sleep,
rest period, relaxation, pacing, diet)
– Equipment to maintain independence
– Education and employment
• Complementary and supplementary care
• Referral to specialist
Treating Co-Morbidities
• Depression/Anxiety - SSRIs/SNRIs
• Pain symptoms - TCAs/Duloxetine
• Sleep Disturbance - BZDs/Non-BZD Hypnotic
Pharmacological treatment
Pharmacological interventions for symptom control
• If chronic pain is a predominant feature - referral to a
pain management clinic
• Prescribing of low-dose tricyclic antidepressants,
specifically amitriptyline, for poor sleep or pain
• Melatonin may be considered for children and young
people with CFS/ME who have sleep difficulties
(NICE, 2007)
Pharmacological treatment
• Drugs with some evidence for CFS
– vitamin B1
– vitamin C
– co-enzyme Q10
– magnesium
– NADH (nicotinamide adenine dinucleotide) or
multivitamins and minerals
(NICE, 2007)
Pharmacological treatment
• Drugs with no evidence in CFS
– monoamine oxidase inhibitors
– glucocorticoids (such as hydrocortisone)
– mineralocorticoids (such as fludrocortisone)
– dexamphetamine
– methylphenidate
– thyroxine
– antiviral agents
(NICE Guidelines, 2007)
RINTATOLIMOD (Ampligen)
• Immunological and Anti-Viral Agent
• Supported by 2 RCTs, awaiting FDA approval
• Acts by stimulating the innate immune system
• Binds to Toll-like Receptor-3 (TLR-3) and increases
production of interferons
• Activates intra-cellular RNAse enzyme – Causes
destruction of viral RNA
(Chambers et al, 2006)
Psychological treatment
• Best evidence base for CBT and GET
• CBT includes
– educating patient about the etiologic model
– setting goals
– restoring fixed bedtime and wake-up time
– challenging and changing fatigue- and activity-related
cognitions
– reducing symptom focusing
– spreading activities evenly throughout the day
– gradually increasing physical activity
– planning a return to work, and resuming other activities
• The intervention, which typically consists of 12–14
sessions spread over 6 months, helps CFS patients gain
control over their symptoms
Psychological treatment
• Graded Exercise Therapy is based on the model of
deconditioning and exercise intolerance and
usually involves
– a home exercise program that continues for 3–5
months.
– Walking or cycling is systematically increased, with set
target heart rates
• The primary component of CBT and GET is a
reduction in fatigue is the change in the patient's
perception of fatigue and focus on symptoms
PACE Trial
• Large-scale five-year trial funded by the UK
government- compared the efficacy and safety of
four treatments:
– Specialist medical care (SMC)
– SMC with CBT
– SMC with GET
– SMC with adaptive pacing therapy (APT)
Randomized control trial
Sample size- 641
PACE Trial
• The percentages (number/total) meeting trial criteria
for recovery were 22% (32/143) after CBT, 22%
(32/143) after GET, 8% (12/149) after APT and 7%
(11/150) after SMC
• CBT or GET, when added to SMC, is an effective
treatment for chronic fatigue syndrome, and that the
size of this effect is moderate
• CBT and GET are the therapies most likely to lead to
recovery
(White et al, 2012)
Course and Outcome
• Small minority of patients recover completely
• Most patients either achieve some improvement or
remain status quo
• Long term follow up studies - Over time many
individuals will not maintain a CFS diagnosis but will
not return to their premorbid level of functioning.
• Psychological factors such as illness attitudes and
coping style seem more important predictors of long
term outcome than immunological or demographic
variables
(Wilson et al, 1994; Brown et al 2012)
Conclusions
• CFS predominantly described in the western
literature
• Significant burden associated
• Dilemma over status as a psychiatric or medical
condition
• No clarity over etiology
• Evidence lacking for pharmacological treatments
• Poor outcome
• Lack of studies in the Indian population
Future Directions
• Multidisciplinary approach to research and
treatment
• Interplay of biological and psycho-social factors in
etiopathogenesis to be studied
• Need for cross-cultural research
• Enhancement of awareness in practicing physicians
and psychiatrists
Thank you

Más contenido relacionado

La actualidad más candente

ARGEC - Assessment of Geriatric Depression
ARGEC - Assessment of Geriatric Depression ARGEC - Assessment of Geriatric Depression
ARGEC - Assessment of Geriatric Depression
kwatkins13
 
Somatoform disorders
Somatoform disordersSomatoform disorders
Somatoform disorders
guest173187
 
Bipolar treatment skilled nursing
Bipolar treatment skilled nursingBipolar treatment skilled nursing
Bipolar treatment skilled nursing
Michael Changaris
 
Somatoform disorder & psychosomatic disorder
Somatoform disorder & psychosomatic disorderSomatoform disorder & psychosomatic disorder
Somatoform disorder & psychosomatic disorder
snich
 

La actualidad más candente (20)

ARGEC - Assessment of Geriatric Depression
ARGEC - Assessment of Geriatric Depression ARGEC - Assessment of Geriatric Depression
ARGEC - Assessment of Geriatric Depression
 
Somatoform disorders
Somatoform disordersSomatoform disorders
Somatoform disorders
 
Bipolar treatment skilled nursing
Bipolar treatment skilled nursingBipolar treatment skilled nursing
Bipolar treatment skilled nursing
 
Somatoform disorder & psychosomatic disorder
Somatoform disorder & psychosomatic disorderSomatoform disorder & psychosomatic disorder
Somatoform disorder & psychosomatic disorder
 
Neurological examination
Neurological examinationNeurological examination
Neurological examination
 
Depression
DepressionDepression
Depression
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Migraine
MigraineMigraine
Migraine
 
Treatment of schizophrenia
Treatment of schizophreniaTreatment of schizophrenia
Treatment of schizophrenia
 
Affective Disorders
Affective DisordersAffective Disorders
Affective Disorders
 
Diagnosis and Treatment of Psychosomatic Disorder (Educational Slides)
Diagnosis and Treatment of Psychosomatic Disorder (Educational Slides)Diagnosis and Treatment of Psychosomatic Disorder (Educational Slides)
Diagnosis and Treatment of Psychosomatic Disorder (Educational Slides)
 
Introduction to psychiatry
Introduction to psychiatryIntroduction to psychiatry
Introduction to psychiatry
 
Neuropathic pain
Neuropathic painNeuropathic pain
Neuropathic pain
 
Depression
DepressionDepression
Depression
 
Neuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsyNeuropsychiatric aspects of epilepsy
Neuropsychiatric aspects of epilepsy
 
Neuropathic pain management
Neuropathic pain managementNeuropathic pain management
Neuropathic pain management
 
Catatonia
CatatoniaCatatonia
Catatonia
 
Psychiatry In Medicine
Psychiatry In MedicinePsychiatry In Medicine
Psychiatry In Medicine
 
Consultation and liaison psychiatry me
Consultation and liaison psychiatry meConsultation and liaison psychiatry me
Consultation and liaison psychiatry me
 
Phsychosomatic disorders
Phsychosomatic disordersPhsychosomatic disorders
Phsychosomatic disorders
 

Destacado

Cvs en fibromyalgie 9maart
Cvs en fibromyalgie 9maartCvs en fibromyalgie 9maart
Cvs en fibromyalgie 9maart
Kine Demonie
 
Pityriasis rosea,lichenoides
Pityriasis rosea,lichenoidesPityriasis rosea,lichenoides
Pityriasis rosea,lichenoides
Ajai Padamadathil
 

Destacado (20)

Chronic fatigue syndrome
Chronic fatigue syndromeChronic fatigue syndrome
Chronic fatigue syndrome
 
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and TreatmentDr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
 
Role of the HPA axis on the Onset of Chronic Fatigue Syndrome
Role of the HPA axis on the Onset of Chronic Fatigue SyndromeRole of the HPA axis on the Onset of Chronic Fatigue Syndrome
Role of the HPA axis on the Onset of Chronic Fatigue Syndrome
 
Chronic Fatigue Synrome
Chronic Fatigue SynromeChronic Fatigue Synrome
Chronic Fatigue Synrome
 
Chronic Fatigue Syndrome (CFS) Treatment
Chronic Fatigue Syndrome (CFS) TreatmentChronic Fatigue Syndrome (CFS) Treatment
Chronic Fatigue Syndrome (CFS) Treatment
 
Chronic fatigue syndrome
Chronic  fatigue syndromeChronic  fatigue syndrome
Chronic fatigue syndrome
 
Hypothalamic–pituitary–adrenal axis
Hypothalamic–pituitary–adrenal axisHypothalamic–pituitary–adrenal axis
Hypothalamic–pituitary–adrenal axis
 
Stress & HPA axis - VCE U4 Psych
Stress & HPA axis - VCE U4 PsychStress & HPA axis - VCE U4 Psych
Stress & HPA axis - VCE U4 Psych
 
Cvs en fibromyalgie 9maart
Cvs en fibromyalgie 9maartCvs en fibromyalgie 9maart
Cvs en fibromyalgie 9maart
 
Cvs en fibromyalgie
Cvs en fibromyalgieCvs en fibromyalgie
Cvs en fibromyalgie
 
Chronic Fatigue Syndrome CFS and homeopathy
Chronic Fatigue Syndrome CFS and homeopathyChronic Fatigue Syndrome CFS and homeopathy
Chronic Fatigue Syndrome CFS and homeopathy
 
Living With Chronic Fatigue Syndrome
Living With Chronic Fatigue SyndromeLiving With Chronic Fatigue Syndrome
Living With Chronic Fatigue Syndrome
 
HUS
HUSHUS
HUS
 
Sam & hpa systems
Sam & hpa systemsSam & hpa systems
Sam & hpa systems
 
Intro, hpa and sam
Intro, hpa and samIntro, hpa and sam
Intro, hpa and sam
 
Cardiac Amyloidosis
Cardiac Amyloidosis Cardiac Amyloidosis
Cardiac Amyloidosis
 
Common Variable Immunodeficiency
Common Variable ImmunodeficiencyCommon Variable Immunodeficiency
Common Variable Immunodeficiency
 
Pityriasis rosea,lichenoides
Pityriasis rosea,lichenoidesPityriasis rosea,lichenoides
Pityriasis rosea,lichenoides
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Thyroid functions and disorders presentation
Thyroid functions and disorders presentationThyroid functions and disorders presentation
Thyroid functions and disorders presentation
 

Similar a Chronic Fatigue Syndrome Current Status

MSOverview_NursingStudents.ppt
MSOverview_NursingStudents.pptMSOverview_NursingStudents.ppt
MSOverview_NursingStudents.ppt
DanaZaytoon
 
Approach to Fatigue
Approach to Fatigue  Approach to Fatigue
Approach to Fatigue
raheef
 
Muscular Dystrophy Presentation (Final)
Muscular Dystrophy Presentation (Final)Muscular Dystrophy Presentation (Final)
Muscular Dystrophy Presentation (Final)
Matthew Reynolds
 

Similar a Chronic Fatigue Syndrome Current Status (20)

WOMEN IN MIND: Women's sleep: Much more than beauty sleep
WOMEN IN MIND: Women's sleep: Much more than beauty sleepWOMEN IN MIND: Women's sleep: Much more than beauty sleep
WOMEN IN MIND: Women's sleep: Much more than beauty sleep
 
Learning Module Eleven: Women's Health
Learning Module Eleven: Women's HealthLearning Module Eleven: Women's Health
Learning Module Eleven: Women's Health
 
Acupuncture for fibromyalgia
Acupuncture for fibromyalgiaAcupuncture for fibromyalgia
Acupuncture for fibromyalgia
 
Rehabilitation in myopathies - dr venugopal kochiyil
Rehabilitation in myopathies  - dr venugopal kochiyilRehabilitation in myopathies  - dr venugopal kochiyil
Rehabilitation in myopathies - dr venugopal kochiyil
 
Fibromylagia
FibromylagiaFibromylagia
Fibromylagia
 
MSOverview_NursingStudents.ppt
MSOverview_NursingStudents.pptMSOverview_NursingStudents.ppt
MSOverview_NursingStudents.ppt
 
Systemic lupus erythematosus (sle)
Systemic lupus erythematosus (sle)Systemic lupus erythematosus (sle)
Systemic lupus erythematosus (sle)
 
Approach to Fatigue
Approach to Fatigue  Approach to Fatigue
Approach to Fatigue
 
Muscular Dystrophy Presentation (Final)
Muscular Dystrophy Presentation (Final)Muscular Dystrophy Presentation (Final)
Muscular Dystrophy Presentation (Final)
 
FM-CFS-Presentation-Compressed.pptx
FM-CFS-Presentation-Compressed.pptxFM-CFS-Presentation-Compressed.pptx
FM-CFS-Presentation-Compressed.pptx
 
Other Chronic Diseases and Conditions
Other Chronic Diseases and ConditionsOther Chronic Diseases and Conditions
Other Chronic Diseases and Conditions
 
Psychological and emotional symptoms in patients suffering from chronc fatigu...
Psychological and emotional symptoms in patients suffering from chronc fatigu...Psychological and emotional symptoms in patients suffering from chronc fatigu...
Psychological and emotional symptoms in patients suffering from chronc fatigu...
 
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: short clinical update
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: short clinical updateChronic Fatigue Syndrome/Myalgic Encephalomyelitis: short clinical update
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: short clinical update
 
Medically Unexplained Symptoms final 2 15 AUG 2022.pptx
Medically Unexplained Symptoms final 2 15 AUG 2022.pptxMedically Unexplained Symptoms final 2 15 AUG 2022.pptx
Medically Unexplained Symptoms final 2 15 AUG 2022.pptx
 
Uncovering Pain: The physiological and psychological components of pain
Uncovering Pain:  The physiological and psychological components of painUncovering Pain:  The physiological and psychological components of pain
Uncovering Pain: The physiological and psychological components of pain
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Aging & frailty
Aging & frailtyAging & frailty
Aging & frailty
 
Thyroid, Adrenals, and Sex Steroids - A Balancing Act
Thyroid, Adrenals, and Sex Steroids - A Balancing ActThyroid, Adrenals, and Sex Steroids - A Balancing Act
Thyroid, Adrenals, and Sex Steroids - A Balancing Act
 
Depression feb2012
Depression feb2012Depression feb2012
Depression feb2012
 
PTA 189 unit 1 ch, 1-4 kk
PTA 189 unit 1 ch, 1-4 kkPTA 189 unit 1 ch, 1-4 kk
PTA 189 unit 1 ch, 1-4 kk
 

Último

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Último (20)

TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 

Chronic Fatigue Syndrome Current Status

  • 1. Chronic Fatigue Syndrome- Current status Presenter – Praveen Das Chairperson – Aditya Hegde
  • 2. Outline • Introduction and evolution of the concept • Definition • Status in ICD • Epidemiology • Etiology • Comorbidity and differential diagnosis • Treatment • Conclusions
  • 3. Introduction • Fatigue- a feeling of weariness, sleepiness or irritability after a period of mental or bodily activity (Comprehensive Text book of Psychiatry, 9th Edition) • Tiredness- A feeling of a lessened capacity for work and reduced efficiency of accomplishment, usually accompanied by a sense of weariness and fatigue (Medicinenet.com) • Weakness- a weak bodily state as expressed by reluctance to an d difficulty in rising, a shuffling, disinclination to mov e, eating slowly and a drooping posture (The free dictionary.com)
  • 4.
  • 5. Evolution of the concept • 19th century - George Miller Beard - “Neurasthenia”  syndrome of fatigue, anxiety, headache, impotence, neuralgia and depression • 1934 - outbreak of fatigue affecting large numbers of doctors and nurses of Los Angeles County Hospital - “Atypical poliomyelitis” • 1955 - similar outbreak in Royal Free Hospital, United Kingdom – “Royal Free disease” or “benign myalgic encephalomyelitis”
  • 6. Evolution of the concept • In 1987 Chronic fatigue syndrome (CFS) first used to describe condition resembling "chronic active Epstein-Barr virus (EBV) infection" but with no evidence of EBV as its cause • In 1988, "Chronic fatigue syndrome: a working case definition", the Holmes definition • In 1994, CDC (Centers for disease control and prevention) gave its case definition
  • 7. CDC Guidelines MAJOR CRITERION Severe chronic fatigue for ≥ 6 months • Not due to ongoing exertion or other medical conditions • Not substantially relieved by rest • Significant interference with daily activities (Fukuda et al, 1994)
  • 8. CDC Guidelines MINOR CRITERION • Concurrent presence of 4 or more of 8 symptoms: • Post-exertion malaise lasting > 24 hours • Unrefreshing sleep • Impairment of memory or concentration • Muscle pain • Pain in multiple joints without swelling or redness • Headaches of a new type, pattern, or severity • Tender lymph nodes in the neck or armpit • Frequent or recurring sore throat that (Fukuda et al, 1994)
  • 9. ICD 10 CM (clinical modification) Chronic Fatigue Unspecified - R53.82 • For ≥ 6 months  tired most of the time, trouble concentrating and carrying out daily activities • Other symptoms include – mild fever – lymphadenopathy – headache – myalgia – arthralgia – depression, and memory loss • Not caused by ongoing exertion, not relieved by rest
  • 10. Epidemiology • Prevalence – 0.4% -2.5% (UK general population) (Jason LA et al 1999) – 0.2-0.4% (USA general population) • Annual direct medical costs - $7 billion in USA • Mean age of onset 29-35 yrs • 75% of affected patients are women (Reyes M et al 2003,, Prins et al 2006)
  • 11. Etiology- Biological 1. Viral infection – Ebstein-Barr virus initially proposed (James F Jones et al 1985) – Later found to be not conclusive – No clear causal relationship between infections and CFS (Timothy Craig, 2003, Buschwald et al 1987) 2. Hypothalamic pituitary adrenal Axis dysfunction – Mild hypocortisolism observed in cases of CFS – HPA axis dysfunction not specific to CFS, symptoms like inactivty in CFS can decrease Cortisol levels (Van Den ede et al.,2007) – Hypocortisolemia may predict a poorer response to CBT (Harrison’s principles of internal medicine, 18th ed)
  • 12. Etiology- Biological 3. Immunologic basis – High pro inflammatory cytokines, high IL-1 levels in CFS (Maes M.,2012) – NK cell dysfunction- either decrease in number or impaired function – increased levels of T regulatory cells (CD25+/FOXP3+) CD4 T cells – Lower activation of CD8 T cells (Currio M., 2013) – Allergies (atopy) and CFS (Y’bars et al 2005)
  • 13. Etiology- Biological 3. Immunological basis (contd) – Serotonin and CFS – anti 5-HT autoimmune activity could play a role in the pathophysiology of CFS and the onset of physio-somatic symptoms (Maes et al 2013)
  • 14. Etiology- Biological 4. Genetics – Concordance 55% in monozygotic and 20% in dizygotic twins (Buchwald et al, 2001) – Sequence variation in genes coding for HTR2A serotonergic receptor potentially enhancing its activity may be involved in pathophysiology of CFS (Smith et al.,2008) – Differences observed in gene expression in exercise responsive genes in terms of gene ontology in attempt to explain fatigue which worsens post exercise in CFS (Whistler et al.,2005)
  • 15. Etiology- Biological 5. Neuroimaging • Functional – Reduced basal ganglia function in terms of decreased activity of right caudate and right globus pallidus on fMRI (Miller et al, 2014) • Structural – Reduced grey and white matter volume in the occipital lobe and reduced grey matter in the right angular gyrus and right parahippocampal gyrus on VBM in CFS patients (Puri et al, 2012)
  • 16. Etiology - Psychological • Increased prevalence of maladaptive personality features and personality disorders • Prevalence of paranoid, schizoid, avoidant, obsessive- compulsive and depressive personality disorders significantly higher in CFS compared to normals • Neuroticism frequently associated with CFS; patients with CFS were found to be less extraverted (Nater et al, 2010)
  • 17. Cognitive deficits in CFS • Impaired information processing speed (reaction time) (Cockshell et al, 2013) • Impaired working memory and poor learning of information (Mitchiels 2001) • Impaired working memory and alterations in motor speed (Majer et al.,`2008)
  • 18. Differential Diagnoses - Medical VERY COMMON (~1 PER 100) Anemia Thyroid disorders Medications (statins) Sleep apnea COMMON (~1 PER 1,000) Chronic infection: HIV, Hepatitis C endocarditis, osteomyelitis, Lyme disease, occult abscess Cancer Pulmonary conditions: asthma, obstructive lung disease, interstitial lung disease Symptomatic hyperparathyroidism UNCOMMON (~1 PER 10,000) Polymyositis, Dermatomyositis, Myopathy Myasthenia gravis, Multiple sclerosis Narcolepsy Inflammatory bowel diseases
  • 19. Overlapping “Functional Syndromes” Functional Somatic Syndromes by Speciality Gastroenterology Irritable Bowel Syndrome, Non-Ulcer Dyspepsia Gynaecology Chronic Pelvic Pain Pre-menstrual syndrome Rheumatology Fibromyalgia Cardiology Atypical/Non-cardiac chest pain DaCosta’s Syndrome Respiratory Medicine Hyperventilation Syndrome Dentistry Temporomandibular Joint Dysfunction/Atypical facial pain ENT Globus Hystericus Allergy Multiple Chemical Sensitivity
  • 20. Fibromyalgia American College of Rheumatology (ACOR) Criteria for Fibromyalgia; Adapted from Wolfe et al, 1990
  • 21. Fibromyalgia vs CFS • Most patients who have received the diagnosis of one are also likely to meet the diagnostic criteria for the other • Simply put, – CFS is fatigue with pain – Fibromyalgia is pain with fatigue (Sullivan et al, 2002)
  • 22. D/D vs Comorbidity - Psychiatric • Major Depression • Anxiety disorders • Somatoform disorder • Hypochondriasis • Neurasthenia • Debated - whether psychiatric conditions are Consequence / Cause / Co-incidental overlap of symptoms • Main overlapping symptoms - fatigue, sleep disturbance, and poor concentration
  • 23. CFS vs Mood & Anxiety disorders • A psychiatric disorder (in patients with an existing diagnosis of CFS) was diagnosed in 45.2%; mostly mood and anxiety disorder. (Mariman et al.,2013) • Studies of clinic attenders with CFS reported that more than 25% have a current DSM major depression diagnosis, and 50%–75% have a lifetime diagnosis (Skapinakis et al, 2000) General Population CFS Patients GAD 3.5% 30% Panic Disorder 5.1% 25%
  • 24. Barriers to making diagnosis • Illness model- a biomedical approach by both doctors (GP) and patients • Poor communication between the patient and the health professional • Knowledge and attitudes- limited understanding, limited training • Low priority in the health care setup (Kerin Bayliss et al, 2014)
  • 25. Indian study • Population survey- Goa • 3000 women- between 18 and 50 yrs • ‘Chronic fatigue’- reported by 12.1% • Factors indicating gender disadvantage (notably sexual violence by the husband and poor mental health were strongly associated with chronic fatigue (Vikram Patel et al, 2005)
  • 26. Treatment - Principles • Engagement: Building rapport, empathic understanding of distress • Developing a therapeutic rationale - individualize • Evolution of a treatment plan: defined by objective performance targets and time frames. • Use psychopharmacology sparingly: Only when a demonstrable symptom target can be seen • Avoid invasive and/or expensive medical testing. • Seek opportunities to clarify importance of psychological factors as the therapy proceeds (Comprehensive Textbook of Psychiatry 9th ed)
  • 27. Treatment - Guidelines NICE Guidelines (2007) • General strategies – Symptom management – Function and quality of life management (sleep, rest period, relaxation, pacing, diet) – Equipment to maintain independence – Education and employment • Complementary and supplementary care • Referral to specialist
  • 28. Treating Co-Morbidities • Depression/Anxiety - SSRIs/SNRIs • Pain symptoms - TCAs/Duloxetine • Sleep Disturbance - BZDs/Non-BZD Hypnotic
  • 29. Pharmacological treatment Pharmacological interventions for symptom control • If chronic pain is a predominant feature - referral to a pain management clinic • Prescribing of low-dose tricyclic antidepressants, specifically amitriptyline, for poor sleep or pain • Melatonin may be considered for children and young people with CFS/ME who have sleep difficulties (NICE, 2007)
  • 30. Pharmacological treatment • Drugs with some evidence for CFS – vitamin B1 – vitamin C – co-enzyme Q10 – magnesium – NADH (nicotinamide adenine dinucleotide) or multivitamins and minerals (NICE, 2007)
  • 31. Pharmacological treatment • Drugs with no evidence in CFS – monoamine oxidase inhibitors – glucocorticoids (such as hydrocortisone) – mineralocorticoids (such as fludrocortisone) – dexamphetamine – methylphenidate – thyroxine – antiviral agents (NICE Guidelines, 2007)
  • 32. RINTATOLIMOD (Ampligen) • Immunological and Anti-Viral Agent • Supported by 2 RCTs, awaiting FDA approval • Acts by stimulating the innate immune system • Binds to Toll-like Receptor-3 (TLR-3) and increases production of interferons • Activates intra-cellular RNAse enzyme – Causes destruction of viral RNA (Chambers et al, 2006)
  • 33. Psychological treatment • Best evidence base for CBT and GET • CBT includes – educating patient about the etiologic model – setting goals – restoring fixed bedtime and wake-up time – challenging and changing fatigue- and activity-related cognitions – reducing symptom focusing – spreading activities evenly throughout the day – gradually increasing physical activity – planning a return to work, and resuming other activities • The intervention, which typically consists of 12–14 sessions spread over 6 months, helps CFS patients gain control over their symptoms
  • 34. Psychological treatment • Graded Exercise Therapy is based on the model of deconditioning and exercise intolerance and usually involves – a home exercise program that continues for 3–5 months. – Walking or cycling is systematically increased, with set target heart rates • The primary component of CBT and GET is a reduction in fatigue is the change in the patient's perception of fatigue and focus on symptoms
  • 35. PACE Trial • Large-scale five-year trial funded by the UK government- compared the efficacy and safety of four treatments: – Specialist medical care (SMC) – SMC with CBT – SMC with GET – SMC with adaptive pacing therapy (APT) Randomized control trial Sample size- 641
  • 36. PACE Trial • The percentages (number/total) meeting trial criteria for recovery were 22% (32/143) after CBT, 22% (32/143) after GET, 8% (12/149) after APT and 7% (11/150) after SMC • CBT or GET, when added to SMC, is an effective treatment for chronic fatigue syndrome, and that the size of this effect is moderate • CBT and GET are the therapies most likely to lead to recovery (White et al, 2012)
  • 37. Course and Outcome • Small minority of patients recover completely • Most patients either achieve some improvement or remain status quo • Long term follow up studies - Over time many individuals will not maintain a CFS diagnosis but will not return to their premorbid level of functioning. • Psychological factors such as illness attitudes and coping style seem more important predictors of long term outcome than immunological or demographic variables (Wilson et al, 1994; Brown et al 2012)
  • 38. Conclusions • CFS predominantly described in the western literature • Significant burden associated • Dilemma over status as a psychiatric or medical condition • No clarity over etiology • Evidence lacking for pharmacological treatments • Poor outcome • Lack of studies in the Indian population
  • 39. Future Directions • Multidisciplinary approach to research and treatment • Interplay of biological and psycho-social factors in etiopathogenesis to be studied • Need for cross-cultural research • Enhancement of awareness in practicing physicians and psychiatrists